Health-tech Startup Orange Health has raised $25 million in its Series B funding round led by Bertelsmann India Investments and General Catalyst.
The round also saw participation from existing investors like Accel, Y Combinator, Good Capital and Uncorrelated Ventures.
In 2021, Orange Health had raised $10 million in a Series A round from Accel.
The company plans to use the funds for product development as well as deep investments in building world-class laboratories in technology, user experience and systems and also plans to expand into new markets and strengthen its teams in operations.
Bengaluru based Orange Health was founded in Dec 2020 by Dhruv Gupta and Tarun Bhambra, It is a diagnostic-tech company, and it has so far provided clinical trial services to over 1 million clients in Bengaluru and the National Capital Region (NCR) and is one of the highest-rated clinical laboratories in the country.
The healthtech company said customers can get tested for a variety of diagnostic tests in just 60 minutes, from 6 am to 10 pm, 7 days a week, from the comfort of their home.
Its customers can currently avail over 2,000 tests in Bengaluru and the NCR.
“In diagnostics, faster is better. While traditional diagnostic labs need patients to come to them at collection centres, most home collection diagnostic companies haven’t been able to reliably provide services in a timely manner. Orange Health’s affordable, on-demand service addresses this market gap. As a tech-enabled diagnostics company built around the customers’, our focus has always been on speed & reliability. With the new round of investments, we are excited to broaden our horizons and reach out to more Indians with real care, real fast”, said, Dhruv Gupta and Tarun Bhambra, Co-Founders, Orange Health.
“With the vision to make healthcare accessible and affordable, Orange Health is bridging the gap between online and offline worlds with the latest consumer tech experience and delivering high-quality healthcare. Over the last two years, healthcare and diagnostics have emerged as a key theme for India and we believe that Orange Health is on a path to turn it seamless for doctors and patients. We are elated to partner with them as today marks the beginning of our commitment to the health tech sector. We aim to partner with more health-tech entrepreneurs disrupting the healthcare sector with an innovation-led approach”, said, Pankaj Makkar, Managing Director of Bertelsmann India Investments.
“Having partnered with Tarun and Dhruv since inception as an early investor, we believe that they are best positioned to innovate and improve the diagnostics supply chain in India. They are demonstrating an incredible ability to create global benchmarks in the speed of collection and test results from the moment a prescription is issued without increasing costs for patients,” said, Anand Chandrasekaran, partner at General Catalyst.
“At the time of Accel’s investment last year, Anand (Daniel) and I believed in Tarun and Dhruv more than the lucrative diagnostics space or the pressing need for digital transformation in healthcare. We are happy to have spotted and backed some of the best founders in healthcare in the country and look forward to our continued partnership,” said, Radhika Ananth, Vice President at Accel.
About Orange Health
Orange Health is among the fastest-growing diagnostic-tech companies in India.
Their vision is to make healthcare seamless for consumers in their homes by enabling doctors to treat their patients in real-time.
To do this, They provide 60 min at-home testing for over 2,000 tests along with fast results.
Consumers love this, and have rated Orange Health 4.9/5 on Google – among the highest-rated diagnostic labs in India!
They combine the latest consumer tech experience with the veracity of high-quality healthcare, giving consumers a mind-blowing experience, where they say ‘its easier than ordering a pizza’
Launched in Bangalore, Gurgaon & Noida. Coming soon to every city! Backed by leading global investors, they have a team of experienced leaders, operators, engineers, medical professionals, and more.